ASX listed biotech Phylogica has identified a next generation cell penetrating peptide that is four times more efficient at delivering a large drug cargo inside cell walls than its original biological product. The discovery was made as the company screens and validates its large library of peptides with a view to discovering even more new cell penetrating peptides. Work on this project will continue until February 2019.
Related Data & Insights
-
-
Rank Company Revenue 87th PYC Therapeutics $15.8m 90th GreenHy2 $15.0m 91st K2fly $14.8m 93rd Advanced Braking Technology $14.7m 94th DTI Group $13.3m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
14 Mar 2024
PYC taps investors for $75m
02 Jan 2024
Nedlands company joins Google in AI project
11 May 2023
Perth biotech company raises $30m
07 Nov 2022
Healthtech banks on rising numbers
15 Jul 2022
Exal Group buys $44m Freo warehouse
13 May 2022
Hockings hopes for blindness drug
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX